Pharmaceutical Composition for Hepatitis Treatment and Applications
    7.
    发明申请
    Pharmaceutical Composition for Hepatitis Treatment and Applications 审中-公开
    用于肝炎治疗和应用的药物组合物

    公开(公告)号:US20110319495A1

    公开(公告)日:2011-12-29

    申请号:US12826257

    申请日:2010-06-29

    申请人: Sheng-Yang Wang

    发明人: Sheng-Yang Wang

    IPC分类号: A61K31/122 A61P29/00

    CPC分类号: A61K31/122

    摘要: A pharmaceutical composition for hepatitis treatment, which comprises lucidone as an active ingredient; and a pharmaceutical acceptable carrier. As lucidone is a natural cyclopentenedione, the pharmaceutical composition of present invention has lesser side effects. The present invention is also related to the application of the pharmaceutical composition.

    摘要翻译: 一种用于肝炎治疗的药物组合物,其包含作为活性成分的荧光素; 和药物可接受的载体。 由于荧光素是天然环戊烯二酮,本发明的药物组合物具有较小的副作用。 本发明还涉及药物组合物的应用。

    Use certain diterpene compounds in the treatment of androgen receptor-associated diseases
    9.
    发明授权
    Use certain diterpene compounds in the treatment of androgen receptor-associated diseases 有权
    使用某些二萜化合物治疗雄激素受体相关疾病

    公开(公告)号:US08519007B2

    公开(公告)日:2013-08-27

    申请号:US12508832

    申请日:2009-07-24

    IPC分类号: A61K31/12

    摘要: The present invention discloses certain diterpenes that can be used to inhibit androgen receptor activity, induce apoptosis and block cell cycle progression of androgen receptor-dependent cells. Androgen receptor has been associated with various diseases such as prostate cancer, androgeneic alopecia, breast cancer, acne etc. Accordingly, the present invention further discloses methods of treating androgen receptor-associated diseases by administering the disclosed diterpenes.

    摘要翻译: 本发明公开了可用于抑制雄激素受体活性,诱导凋亡并阻断雄激素受体依赖性细胞的细胞周期进程的某些二萜烯。 雄激素受体与各种疾病如前列腺癌,雄激素性脱发,乳腺癌,痤疮等有关。因此,本发明还公开了通过施用所公开的二萜来治疗雄激素受体相关疾病的方法。